Board of Directors

In 2018, the Board of Directors consisted of six members who are elected for one year by the Annual General Meeting. According to the Articles of Association, the Board of Directors shall consist of at least three and a maximum of ten members with a maximum of ten deputies. The Board of Directors elects its officers at a meeting held immediately after the Annual General Meeting.

Holdings in Enzymatica March 31, 2019

Bengt Baron
Bengt Baron
Born 1962 Chairman of the Board December 2016

Chairman of the Board of MIPS AB, Thule Group AB (publ) and 5653 Sweden AB. Board member of AAK AB. Bengt was previously CEO of Cloetta AB and Leaf International B.V.

Education: MA and MBA, University of California, Berkeley

Independent of the company and its management, as well as its major shareholders.

Holdings in Enzymatica: 614,277 shares, 450,000 warrants.

Marianne Dicander Alexandersson
Marianne Dicander Alexandersson
Born 1959. Member of the Board since May 2014

CEO of her own company, MDA Management AB. Previous positions include CEO of Global Health Partners AB, the Sixth Swedish National Pension Fund, and Kronans Droghandel, as well as Deputy CEO of Apoteket AB.

Other directorships: Chairman of the Board of Sahlgrenska Science Park, Board member for Praktikertjänst, Camurus AB, Recipharm AB, Addera Care AB, and Promore AB, as well as member of the advisory committee for the Swedish Dental and Pharmaceutical Benefits Authority (TLV) and Skandia’s council.

Education: M.Sc. chemical engineering.

Independent of the company and its management, as well as its major shareholders.

Holdings in Enzymatica: 72,912 shares.

Mats K Andersson
Mats K Andersson
Born 1955 Member of the Board since December 2016.

Chairman of the Board of Lomond Invest AB, Abanico Invest AB and Andersson & Co AB, as well as Board member of Volati Parts AB and Hills Golf AB. Mats was previously CEO of Lomond Industrier AB and business area manager and Executive Vice President of LICare AB (publ).

Education: BSc. International Business from Lund University.

Holdings in Enzymatica: 27,837,483 shares in the Company (directly and indirectly through company).

Sigurgeir Guðlaugsson
Sigurgeir Guðlaugsson
Born: 1976. Member of the Board since February 2016

Previous positions include CEO of Zymetech ehf, ​CEO of Novator Healthcare and Global Head of Mergers & Acquisitions for the Actavis Group ehf, founder and CEO of Citalfort Consulting slf, Board member of Straumur Investment hf, as well as partner at H.F. Securities hf and Board member of Zymetech Takanawa Iceland ehf.​

Education: B.Sc. International Business.

Holdings in Enzymatica: 1,002,001 shares.

Louise Nicolin
Louise Nicolin
Born 1973 Member of the Board since December 2016.

Board member for Better Business World Wide as well as Board member for Volati AB (publ), VBG Group AB (publ), Dellner Couplers AB, Simris Alg (publ) and Uppdragshuset Sverige AB. Has run the consultancy at Nicolin Consulting AB since 2011, with a focus on business development and quality assurance. She was previously business area manager and head consultant at PlantVision.

Education: M.Sc. Eng. Molecular biotechnology from Uppsala University. eMBA Stockholm University and “International Directors Programme (IDP-c), Insead.

Independent of the company and its management, as well as its major shareholders.

Holdings in Enzymatica: 23,000 shares.

Gudmundur Palmason
Gudmundur Palmason
Born: 1968. Member of the Board since February 2016

CEO of Strax Group GmbH. Extensive experience in international business and contract law. Previous positions include Board member for Zymetech ehf. and Deputy Board member for MP Bank hf (Kvika Bank).

Education: LL.M, MBA and Cand.Jur.

Holdings in Enzymatica: 9,360,622 shares.